Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • dinepat203 dinepat203 Dec 3, 2012 11:02 AM Flag

    NASDAQ:RGLS (ISIS owned) Closing Bell at NASDAQ

    Regulus was formed in September 2007 by Alnylam Pharmaceuticals (NASDAQ:ALNY) and Isis Pharmaceuticals (NASDAQ:ISIS). Regulus benefits substantially from the collective therapeutic RNA expertise of its founding companies, including established proprietary oligonucleotide-based technologies, and broad and dominant intellectual property estates specific to chemically modified oligonucleotides. Regulus has access to over 900 patents and patent applications pertaining to oligonucleotide technologies useful for targeting microRNA therapeutics, and over 150 patents and patent applications directed to microRNA specific technologies.

    Sentiment: Strong Buy

 
ISIS
54.40+0.72(+1.34%)Jul 28 4:00 PMEDT